Improving the quality of life in patients with idiopathic Parkinson's disease through individualized holistic care within the framework of the Cologne PD Network

Improving the quality of life in patients with idiopathic Parkinson's disease through individualized holistic care within the framework of the Cologne PD Network - CPN

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00003452

Enrollment

300

Registered

2011-12-23

Start date

2012-01-02

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G20

Interventions

Group 1: intensified holistic treatment of patients with Parkinson's disease as part of the Cologne Parkinson network through regular visits of a specialist from the University Hospital at resident ne

Eligibility

Sex/Gender

All

Age

25 Years to 85 Years

Inclusion criteria

Inclusion criteria: • male and female patients with clinical diagnosis of idiopathic Parkinson syndrome (IPS) • Patients aged between 25 and 85 years • patients must be able to consent and sign a consent form • patients must have good knowledge of German

Exclusion criteria

Exclusion criteria: • Patients who suffer from a cognitive-impairing disease (eg. vascular events, tumors, etc.) • Patients with depression (BDI> 30 points) and/or dementia (PANDA <14 points) • Expected incompliance of participation in the study

Design outcomes

Primary

Measure	Time frame
Survey of quality of life at baseline and after six months by a questionnaire (Parkinson's Disease Quality of Life Questionnaire (PDQ-39))	—

Secondary

Measure	Time frame
Survey of the following parameters at baseline and after six months: Disease stage: Hoehn & Yahr scale (assessment by physician) Disease severity: United Parkinson's Disease Rating Scale (UPDRS) Part III (video recording, blinded assessment by physician) Non-motor symptoms: non-motor symptoms scale (NMS) (Questionnaire) Depression: Beck's Depression Inventory (BDI) (Questionnaire) cognitive deficits: Psychometric Neuroscience Parkinson Dementia Assessment (PANDA) (Questionnaire) Phases of over- or undermobility: movement diary Medication: Medication Diary	—

Measure

Time frame

Survey of the following parameters at baseline and after six months: Disease stage: Hoehn & Yahr scale (assessment by physician) Disease severity: United Parkinson's Disease Rating Scale (UPDRS) Part III (video recording, blinded assessment by physician) Non-motor symptoms: non-motor symptoms scale (NMS) (Questionnaire) Depression: Beck's Depression Inventory (BDI) (Questionnaire) cognitive deficits: Psychometric Neuroscience Parkinson Dementia Assessment (PANDA) (Questionnaire) Phases of over- or undermobility: movement diary Medication: Medication Diary

—

Countries

Germany

Contacts

Public ContactLars Timmermann

Uniklinik Köln Klinik für Neurologie

lars.timmermann@uk-koeln.de0221/4787494

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026